Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Linoleic acid inhibits lipopolysaccharide-induced inflammation by promoting TLR4 regulated autophagy in murine RAW264.7 macrophages

Y. Qin, K. Li, Q. Zhang, J. Liu, Y. Xie, T. Zhang, X. Wang, L. Zhang, Y. Jiang, G. Liu

. 2024 ; 22 (4) : 185-196. [pub] 20241205

Language English Country Czech Republic

Document type Journal Article

Grant support
2022MSXM006 Chongqing Municipal Public Health Bureau of Chongqing People - China
2023MSXM106 Graduate Innovative Special Fund Projects of Chongqing - China
CYS22385 Graduate Innovative Special Fund Projects of Chongqing - China

Linoleic acid (LA), an essential fatty acid, has emerged as a pivotal regulator in disorders associated with inflammation in recent years; however, the underlying mechanisms are still not completely understood. We utilized network pharmacology and experimental methodologies to elucidate the mechanisms underlying the anti-inflammatory effects of LA. Our network pharmacology analysis revealed that LA shares common targets with sepsis. These targets are enriched in various pathways comprising C-type signaling pathway, PI3K-Akt signaling pathway, toll-like receptor signaling pathway, neutrophil extracellular trap formation, AMPK signaling pathway, and autophagy-animal. These findings suggest that LA may exert regulatory effects on inflammation and autophagy during sepsis. Subsequently, we established in vivo and ex vivo models of sepsis using lipopolysaccharide (LPS) in experimental study. Treatment with LA reduced lung damage in mice with LPS-induced lung injury, and reduced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in plasma, bronchoalveolar lavage fluid (BALF), and peritoneal lavage fluid (PLF). LA also decreased the production of TNF-α and IL-6 in RAW264.7 macrophages exposed to LPS. In LPS-induced RAW264.7 macrophages, LA induced an elevation in LC3-II while causing a reduction in p62, which was associated with downregulation of toll-like receptor 4 (TLR4). We utilized 3-methyladenine (3-MA) to inhibit the autophagic activity, which reversed the modulatory effects of LA on LC3-II and p62. 3-MA also prevented the decline in TLR4 expression along with reduction in pro-inflammatory cytokines secretion. Our findings suggest that the activation of autophagy by LA may lead to the downregulation of TLR4, thereby exerting its anti-inflammatory effects.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25011856
003      
CZ-PrNML
005      
20250521143004.0
007      
ta
008      
250506s2024 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2024.023 $2 doi
035    __
$a (PubMed)40033806
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Qin, Yin $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
245    10
$a Linoleic acid inhibits lipopolysaccharide-induced inflammation by promoting TLR4 regulated autophagy in murine RAW264.7 macrophages / $c Y. Qin, K. Li, Q. Zhang, J. Liu, Y. Xie, T. Zhang, X. Wang, L. Zhang, Y. Jiang, G. Liu
520    9_
$a Linoleic acid (LA), an essential fatty acid, has emerged as a pivotal regulator in disorders associated with inflammation in recent years; however, the underlying mechanisms are still not completely understood. We utilized network pharmacology and experimental methodologies to elucidate the mechanisms underlying the anti-inflammatory effects of LA. Our network pharmacology analysis revealed that LA shares common targets with sepsis. These targets are enriched in various pathways comprising C-type signaling pathway, PI3K-Akt signaling pathway, toll-like receptor signaling pathway, neutrophil extracellular trap formation, AMPK signaling pathway, and autophagy-animal. These findings suggest that LA may exert regulatory effects on inflammation and autophagy during sepsis. Subsequently, we established in vivo and ex vivo models of sepsis using lipopolysaccharide (LPS) in experimental study. Treatment with LA reduced lung damage in mice with LPS-induced lung injury, and reduced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in plasma, bronchoalveolar lavage fluid (BALF), and peritoneal lavage fluid (PLF). LA also decreased the production of TNF-α and IL-6 in RAW264.7 macrophages exposed to LPS. In LPS-induced RAW264.7 macrophages, LA induced an elevation in LC3-II while causing a reduction in p62, which was associated with downregulation of toll-like receptor 4 (TLR4). We utilized 3-methyladenine (3-MA) to inhibit the autophagic activity, which reversed the modulatory effects of LA on LC3-II and p62. 3-MA also prevented the decline in TLR4 expression along with reduction in pro-inflammatory cytokines secretion. Our findings suggest that the activation of autophagy by LA may lead to the downregulation of TLR4, thereby exerting its anti-inflammatory effects.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a autofagie $x účinky léků $7 D001343
650    12
$a toll-like receptor 4 $x metabolismus $7 D051197
650    12
$a lipopolysacharidy $x toxicita $7 D008070
650    _2
$a RAW 264.7 buňky $7 D000067996
650    12
$a zánět $x metabolismus $x farmakoterapie $x chemicky indukované $x patologie $7 D007249
650    12
$a kyselina linolová $x farmakologie $7 D019787
650    12
$a makrofágy $x účinky léků $x metabolismus $x imunologie $7 D008264
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a sepse $x chemicky indukované $x farmakoterapie $x metabolismus $x imunologie $7 D018805
655    _2
$a časopisecké články $7 D016428
700    1_
$a Li, Kexin $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
700    1_
$a Zhang, Qiuhong $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
700    1_
$a Liu, Jie $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
700    1_
$a Xie, Yu $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
700    1_
$a Zhang, Tingting $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
700    1_
$a Wang, Xiaoliang $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
700    1_
$a Zhang, Li $u Chongqing Medical University, Department of Pathophysiology, Chongqing 400016, China
700    1_
$a Jiang, Yu $u University-Town Hospital of Chongqing Medical University, Department of Respiratory and Critical Care Medicine, Chongqing 401331, China
700    1_
$a Liu, Gang $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
773    0_
$w MED00012667 $t Journal of applied biomedicine $x 1214-0287 $g Roč. 22, č. 4 (2024), s. 185-196
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40033806 $y Pubmed
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20250506 $b ABA008
991    __
$a 20250521143002 $b ABA008
999    __
$a ok $b bmc $g 2324884 $s 1248946
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 22 $c 4 $d 185-196 $e 20241205 $i 1214-0287 $m Journal of applied biomedicine $n J Appl Biomed $x MED00012667
GRA    __
$a 2022MSXM006 $p Chongqing Municipal Public Health Bureau of Chongqing People $2 China
GRA    __
$a 2023MSXM106 $p Graduate Innovative Special Fund Projects of Chongqing $2 China
GRA    __
$a CYS22385 $p Graduate Innovative Special Fund Projects of Chongqing $2 China
LZP    __
$b NLK124 $a Pubmed-20250506

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...